Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
87,001,862
-
Total 13F shares
-
68,584,982
-
Share change
-
+4,168,035
-
Total reported value
-
$1,942,401,972
-
Put/Call ratio
-
1.3%
-
Price per share
-
$28.27
-
Number of holders
-
162
-
Value change
-
+$106,818,236
-
Number of buys
-
80
-
Number of sells
-
86
Institutional Holders of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) as of Q1 2021
As of 31 Mar 2021 Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) had 162 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 68,584,982 shares of stock of the company.
Largest 10 holders included FMR LLC, BlackRock Inc., Avoro Capital Advisors LLC, EcoR1 Capital, LLC, VANGUARD GROUP INC, STATE STREET CORP, AMERIPRISE FINANCIAL INC, Holocene Advisors, LP, Foresite Capital Management IV, LLC, and Invesco Ltd..
This table shows 162 institutional shareholders of the security as of 31 Mar 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.